Skip to main content

Vislink Reports First Quarter 2026 Financial Results

MT. OLIVE, N.J., May 15, 2026 (GLOBE NEWSWIRE) — Vislink Technologies, Inc. (“Vislink” or the “Company”) (OTCID: VISL), a global leader in real-time video communications for the defense, public safety, and broadcast markets, today reported financial and operational results for the first quarter ended March 31, 2026. CEO Commentary “Q1 2026 was a landmark quarter for Vislink,” said Mickey Miller, Chief Executive Officer. “For the first time in the Company’s recent history, we delivered EBITDA profitability—a non-GAAP EBITDA profit of $0.2 million versus a loss of $2.2 million in the same quarter last year. Revenue of $5.4 million increased 17% from the prior year period and 2% sequentially from Q4 2025, supported by strong order intake in Q4 that translated into healthy Q1 shipments. Gross margin of 65.0% expanded meaningfully from...

Continue reading

Yili Group Reports FY2025 Dual Growth in Revenue and Profit, Marking 500-Fold Revenue Surge in 30 Years Since Its Listing

HOHHOT, China, May 15, 2026 (GLOBE NEWSWIRE) — On April 29, 2026, Yili Group released its FY2025 Annual Report and FY2026 Q1 Report, delivering record-high performance. In 2025, the company posted total revenue of RMB 115.931 billion, and net profit attributable to owners of the parent of RMB 11.565 billion, up 36.82% year-on-year. As a comprehensive dairy enterprise, Yili achieved “dual growth” in both revenue and profit. In the first quarter of 2026, the company’s revenue and adjusted net profit attributable to owners of the parent both hit new highs.A Media Snippet accompanying this announcement is available by clicking on this link. In 2025, Yili’s operations across all categories continued to lead the industry. The core liquid milk segment firmly maintained its No. 1 position with an expanding lead....

Continue reading

Reading International Reports First Quarter 2026 Results

Earnings Call Webcast to Discuss First Quarter Financial Results Scheduled to Post to Corporate Website on Tuesday, May 19, 2026 NEW YORK, May 15, 2026 (GLOBE NEWSWIRE) — Reading International, Inc. (NASDAQ: RDI) (“Reading” or our “Company”), an internationally diversified cinema and real estate company with operations and assets in the United States, Australia, and New Zealand, today announced its results for the First Quarter ended March 31, 2026. Key Financial Summary Results –First Quarter 2026Total Revenues of $45.1 million increased by 12% from $40.2 million in Q1 2025. Representing the best result for this metric since Q1 2019, a reported Operating Loss of $3.6 million marks a 47% improvement from a $6.9 million Operating Loss reported in Q1 2025. EBITDA decreased to a negative EBITDA of $0.8 million compared to a positive...

Continue reading

SurgePays Reports First Quarter 2026 Revenue of Approximately $16 Million, Up 51% Year-Over-Year Driven by Point of Sale and Prepaid Services Growth of 71%

Cost discipline initiated in 2025 drove G&A expenses down approximately 25% Revenue growth was led by point of sale and prepaid services Total wireless subscriber lines surpassed 200,000 across LinkUp Mobile and Torch Wireless BARTLETT, Tenn., May 15, 2026 (GLOBE NEWSWIRE) — SurgePays, Inc. (NASDAQ: SURG), a fintech and mobile virtual network operator serving the approximately 138 million subprime consumers in the United States, today reported its financial results for the quarter ended March 31, 2026. “The first quarter of 2026 is the quarter where the diversification work of the last twelve months becomes visible in the numbers,” said Brian Cox, Chief Executive Officer of SurgePays. “Revenue grew approximately 51% year-over-year, driven by an approximately 71% increase in point of sale and prepaid services. Additionally,...

Continue reading

Vaso Corporation Announces Financial Results for First Quarter of 2026

PLAINVIEW, N.Y., May 15, 2026 (GLOBE NEWSWIRE) — Vaso Corporation (“Vaso”) (OTCQX: VASO), a leading MedTech company with a diversified business portfolio in network and IT services, professional sales services, and proprietary medical products, today announced its operating results for the three months ended March 31, 2026. “For the first quarter of 2026, the Company recorded total revenue of $19.4 million, a decrease of 0.5% when compared to the same quarter of the prior year, but an increase of 4.8% when excluding revenue of the healthcare IT service business we divested in November 2025,” commented Dr. Jun Ma, President and Chief Executive Officer of Vaso Corporation. “Gross profit for the quarter was $11.6 million, up by 1.9% year over year, or by 5.8% without the healthcare IT service business; and net loss for the first three...

Continue reading

Kartoon Studios Reports Q1 2026 Results

Building on 2025 Momentum as Operating Performance Improves and the Company Scales Its IP-Driven Strategy  Distribution Revenue Climbs 15% Compared to Prior Year Period as Streamers, Kartoon Channel! and Ameba Expand Engagement and Monetization Kartoon Channel Continues Strategic Expansion of Globally Recognized Entertainment Brands With Licensing Deal for Mattel’s Animated Series Masters of the Universe (2002) and American Girl (2016) Operating Costs Decline 20% as Loss From Operations Continues to Narrow Year-Over-Year Reflecting Continued Operating Discipline  Flagship Franchises, “Hundred Acre Wood” and “Stan Lee Universe”, Advance Toward Commercialization and Long-Term Monetization   BEVERLY HILLS, Calif., May 15, 2026 (GLOBE NEWSWIRE) — Kartoon Studios (NYSE American: TOON) today reported financial results for the...

Continue reading

Propanc Biopharma Provides Corporate Update and Reports Third Quarter 2025/26 Results

Entering a Transformative Stage by Advancing PRP to a Pivotal, Phase 1b, FIH, Clinical Study Whilst Undertaking Additional Research into Age-Related Chronic Diseases MELBOURNE, Australia, May 15, 2026 (GLOBE NEWSWIRE) — Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company focused on developing novel treatments for chronic diseases, including recurrent and metastatic cancer, today announced an update on corporate progress and reported third quarter financial results as of March 31, 2026 (Year end June 30). Corporate and R&D Highlights Executes Service Agreement with FyoniBio GmbH to Establish & Validate Pharmacokinetics Assay for Phase 1b First-In-Human Study Management has executed a service agreement with FyoniBio GmbH (formerly Glycotope, est. 2010), a German Contract Development...

Continue reading

60 Degrees Pharmaceuticals Announces First Quarter 2026 Results

WASHINGTON, May 15, 2026 (GLOBE NEWSWIRE) — 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company focused on developing new medicines for infectious diseases, today reported its financial results for the first quarter of fiscal year 2026, ended March 31, 2026. Financial Highlights for the Quarter Ended March 31, 2026:Net product revenues decreased approximately 1% from $164 thousand for the first quarter of 2025 to approximately $162 thousand for the first quarter of 2026. The Company achieved a gross profit of approximately $76 thousand in the first quarter of 2026, compared with a gross profit of approximately $90 thousand in the first quarter of 2025. Operating expenses were approximately $2.17 million in the first quarter of 2026, compared with approximately $2.09 million in the...

Continue reading

Data Storage Corporation Provides First Quarter 2026 Business Update

Highlights Strategic Expansion into AI Continuity Infrastructure for Regulated Industries Conference Call to be Held Today at 11:00 am ET NEW YORK, May 15, 2026 (GLOBE NEWSWIRE) — Data Storage Corporation (Nasdaq: DTST) (“DTST” and the “Company”), today provided a business update for the first quarter ended March 31, 2026, highlighting the Company’s strategic initiatives focused on emerging AI infrastructure opportunities and regulated enterprise continuity solutions. Business Highlights:Launching Sovereign AI Solutions (SaiS): Establishing a wholly owned subsidiary, Sovereign AI Solutions (“SaiS”), focused on developing a purpose-built AI Continuity Control Plane for regulated industries designed to support recovery, validation, and compliance for sovereign AI and AI Factory environments across sectors such as healthcare, financial...

Continue reading

HeartCore Reports First Quarter 2026 Financial Results

NEW YORK and TOKYO, May 15, 2026 (GLOBE NEWSWIRE) — HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or the “Company”), an IPO consulting services company based in Tokyo, reported financial results for the first quarter ended March 31, 2026. Recent Operational HighlightsAs of March 31, 2026, HeartCore was engaged with 16 Go IPO clients, including 6 clients currently in various stages of preparation for potential public registrations and U.S. exchange listings Regained Nasdaq $1.00 minimum bid price requirement Authorized $2.0 million share repurchase programManagement CommentaryHeartCore CEO Sumitaka Kanno commented: “During the first quarter of 2026, HeartCore continued to advance its strategic focus on financial services and capital markets-related services, with Go IPO remaining the key contributor for coming quarters....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.